Literature DB >> 4116201

Therapeutic approaches to tardive dyskinesia. A review of the literature.

H Kazamatsuri, C Chien, J O Cole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4116201     DOI: 10.1001/archpsyc.1972.01750280059011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  11 in total

1.  Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.

Authors:  H A McClelland
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

2.  Deanol in tardive dyskinesia.

Authors:  L De Silva; C Y Huang
Journal:  Br Med J       Date:  1975-08-23

3.  Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.

Authors:  B K Koe
Journal:  Experientia       Date:  1975-06-15

Review 4.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

5.  Tardive dyskinesia: age and sex differences in hospitalized schizophrenics.

Authors:  J M Smith; W T Oswald; L T Kucharski; L J Waterman
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

6.  Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.

Authors:  C de Montigny; G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

7.  An assessment of tardive dyskinesia in schizophrenic outpatients.

Authors:  J M Smith; L T Kucharski; C Eblen; E Knutsen; C Linn
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

8.  Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Sulpiride in tardive dyskinesia.

Authors:  M Schwartz; L Moguillansky; G Lanyi; B Sharf
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

10.  A study of prophylactic value of antiparkinsonian drug.

Authors:  P B Behere; P Ramakrishna
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.